ACCELERATE	Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High-Risk for Vascular Outcomes
ApoB	Apolipoprotein B
ASCVD	Atherosclerotic cardiovascular disease
BROADWAY	The Randomized Study to Evaluate the Effect of Obicetrapib on top of Maximum Tolerated Lipid-Modifying Therapies
BROOKLYN	Evaluate the Effect Of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on top of Maximum Tolerated Lipid-Modifying Therapies
CVD	Cardiovascular disease
CETP	Cholesteryl Ester Transfer Protein
Dal-OUTCOMES	Dalcetrapib on Cardiovascular Mortality and Morbidity in Clinically Stable Patients with a Recent Acute Coronary Syndrome
Dal-PLAQUE	Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging;
Dal-VESSEL	A Study Assessing the Effect of Dalcetrapib on Vascular Function in Patients with Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients
HDL	High-density lipoprotein
HDL-C	High-density lipoprotein cholesterol
HPS	Heart protection study
ILLUMINATE	Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events
LDL	Low-density lipoprotein
LDL-C	Low-density lipoprotein cholesterol
MACE	Major adverse cardiovascular events
MI	Myocardial infarction
OCEAN	Randomized Study of Obicetrapib in Combination with Ezetimibe
PREVAIL	Cardiovascular Outcome Study to Evaluate the Effect Of Obicetrapib in Patients with Cardiovascular Disease
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
RCTs	Randomized controlled trials
REALIZE	Anacetrapib as Lipid-Modifying Therapy in Patients with Heterozygous Familial Hypercholesterolaemia
REVEAL	Evaluation of the Effects of Anacetrapib Through Lipid Modification
ROSE	Randomized Study of Obicetrapib as an Adjunct to Statin Therapy
ROSE2	Study to Evaluate the Effect of Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy
TIMI	Thrombolysis In Myocardial Infarction
TULIP	TA-8995 (obicetrapib): Its Use in Patients with Mild Dyslipidaemia
VLDL	Very low-density lipoprotein